How can we support your ADC manufacturing as a CDMO?

Описание к видео How can we support your ADC manufacturing as a CDMO?

We have more than 35 years of experience in bioconjugation. Lisa McDermott, Director, Process and Analytic Development, shares how we work with Antibody-drug conjugates (ADC) innovators to speed the delivery of these promising therapies to patients.

Комментарии

Информация по комментариям в разработке